Personal Products
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Technicals: Bullish SharesGuru indicator.
Dividend: Dividend paying stock. Dividend yield of 2.39%.
Balance Sheet: Strong Balance Sheet.
Profitability: Very strong Profitability. One year profit margin are 23%.
Smart Money: Smart money has been increasing their position in the stock.
Size: Market Cap wise it is among the top 20% companies of india.
Past Returns: Underperforming stock! In past three years, the stock has provided -8% return compared to 13.3% by NIFTY 50.
Momentum: Stock is suffering a negative price momentum. Stock is down -9.4% in last 30 days.
Growth: Declining Revenues! Trailing 12m revenue has fallen by -20.8% in past one year. In past three years, revenues have changed by -12.9%.
Valuation | |
|---|---|
| Market Cap | 35.33 kCr |
| Price/Earnings (Trailing) | 45.39 |
| Price/Sales (Trailing) | 10.24 |
| EV/EBITDA | 31.82 |
| Price/Free Cashflow | 85.05 |
| MarketCap/EBT | 33.69 |
| Enterprise Value | 34.55 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 3.45 kCr |
| Rev. Growth (Yr) | 1.3% |
| Earnings (TTM) | 778.42 Cr |
| Earnings Growth (Yr) | 12.2% |
Profitability | |
|---|---|
| Operating Margin | 30% |
| EBT Margin | 30% |
| Return on Equity | 83.59% |
| Return on Assets | 36.49% |
| Free Cashflow Yield | 1.18% |
Growth & Returns | |
|---|---|
| Price Change 1W | -4.1% |
| Price Change 1M | -9.4% |
| Price Change 6M | -19.3% |
| Price Change 1Y | -19.3% |
| 3Y Cumulative Return | -8% |
| 5Y Cumulative Return | -3.5% |
| 7Y Cumulative Return | 0.80% |
| 10Y Cumulative Return | 5.7% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -34.28 Cr |
| Cash Flow from Operations (TTM) | 593.21 Cr |
| Cash Flow from Financing (TTM) | -666.23 Cr |
| Cash & Equivalents | 782.1 Cr |
| Free Cash Flow (TTM) | 538.18 Cr |
| Free Cash Flow/Share (TTM) | 165.79 |
Balance Sheet | |
|---|---|
| Total Assets | 2.13 kCr |
| Total Liabilities | 1.2 kCr |
| Shareholder Equity | 931.27 Cr |
| Current Assets | 1.49 kCr |
| Current Liabilities | 1.09 kCr |
| Net PPE | 166.04 Cr |
| Inventory | 216.24 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 85.05 |
| Interest/Cashflow Ops | 42.05 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 260 |
| Dividend Yield | 2.39% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Technicals: Bullish SharesGuru indicator.
Dividend: Dividend paying stock. Dividend yield of 2.39%.
Balance Sheet: Strong Balance Sheet.
Profitability: Very strong Profitability. One year profit margin are 23%.
Smart Money: Smart money has been increasing their position in the stock.
Size: Market Cap wise it is among the top 20% companies of india.
Past Returns: Underperforming stock! In past three years, the stock has provided -8% return compared to 13.3% by NIFTY 50.
Momentum: Stock is suffering a negative price momentum. Stock is down -9.4% in last 30 days.
Growth: Declining Revenues! Trailing 12m revenue has fallen by -20.8% in past one year. In past three years, revenues have changed by -12.9%.
Investor Care | |
|---|---|
| Dividend Yield | 2.39% |
| Dividend/Share (TTM) | 260 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 239.81 |
Financial Health | |
|---|---|
| Current Ratio | 1.37 |
| Debt/Equity | 0.00 |
Technical Indicators | |
|---|---|
| RSI (14d) | 5.32 |
| RSI (5d) | 1.73 |
| RSI (21d) | 17.36 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Buy |
| SharesGuru Signal | Buy |
| RSI Signal | Buy |
| RSI5 Signal | Buy |
| RSI21 Signal | Buy |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Updated May 5, 2025
Procter & Gamble's revenue of $19.78 billion fell short of the anticipated $20.11 billion.
The company cut its full-year core earnings and revenue forecasts due to a consumer slowdown and rising tariffs.
Insider selling has increased, including a significant sale by CEO Gary Coombe, which suggests negative sentiment about the stock.
J.P. Morgan analyst Andrea Faria Teixeira maintained a Buy rating on Procter & Gamble with a price target of $169.00.
Truist Financial also gave a Buy rating for Procter & Gamble, with a higher price target of $180.00.
Procter & Gamble reported quarterly earnings of $1.54 per share, surpassing expectations.
This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.
Summary of Procter & Gamble Hygiene & Health Care's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Understand Procter & Gamble Hygiene & Health Care ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Procter And Gamble Overseas India B.V. | 68.73% |
| SBI Focused Fund | 4.97% |
| Temple Trees Impex And Investment Private Limited | 1.91% |
| ICICI Prudential Large Cap Fund | 1.87% |
| General Insurance Corporation of India | 1.66% |
| Procter & Gamble Arabia L.L.C. | 0% |
| Procter & Gamble Asia Pte. Ltd. | 0% |
| Procter & Gamble Australia Proprietary Limited | 0% |
| Procter & Gamble Azerbaijan Services LLC | 0% |
| Procter & Gamble Bangladesh Private Ltd. | 0% |
| Procter & Gamble Blois S.A.S. | 0% |
| Procter & Gamble Brazil Holdings B.V. | 0% |
| Procter & Gamble Bulgaria EOOD | 0% |
| Procter & Gamble Business Services Canada Company | 0% |
| Procter & Gamble Canada Holding B.V. | 0% |
| Procter & Gamble Chile Limitada | 0% |
| Procter & Gamble CM Sarl | 0% |
| Procter & Gamble CM 2 Sarl | 0% |
| Procter & Gamble Colombia Ltda. | 0% |
| Procter & Gamble Commercial LLC | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Procter & Gamble Hygiene & Health Care against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| HINDUNILVR | Hindustan Unilever | 5.23 LCr | 65.66 kCr | -6.10% | +0.30% | 36.04 | 7.96 | - | - |
| NESTLEIND | Nestle India | 2.42 LCr | 21.94 kCr | -3.90% | +13.80% | 73.76 | 11.01 | - | - |
| GODREJCP | Godrej Consumer Products | 1.14 LCr | 15.46 kCr | -3.40% | +8.40% | 62.7 | 7.39 | - | - |
| MARICO | Marico | 1.02 LCr | 13.2 kCr | +7.10% | +29.20% | 59.31 | 7.72 | - | - |
| DABUR | Dabur India | 84.89 kCr | 13.55 kCr | -4.50% | -3.30% | 45.93 | 6.26 | - | - |
Comprehensive comparison against sector averages
PGHH metrics compared to Personal
| Category | PGHH | Personal |
|---|---|---|
| PE | 45.39 | 48.36 |
| PS | 10.24 | 7.34 |
| Growth | -20.8 % | 1.1 % |
Procter & Gamble Hygiene & Health Care is a prominent Personal Care company with the stock ticker PGHH. It boasts a substantial market capitalization of Rs. 46,360.4 Crores.
The company specializes in the manufacture and sale of branded packaged fast-moving consumer goods, focusing on feminine care and healthcare sectors both in India and internationally. Procter & Gamble Hygiene and Health Care operates through two main segments: Healthcare Products and Hygiene Products.
In terms of offerings, the company provides a wide range of health care products, which include ointments, creams, cough drops, and tablets. Its hygiene product line encompasses feminine hygiene products and other skin care items, including feminine care pads. Additionally, they offer baby care products such as nappies, pants, and baby wipes, as well as grooming products, laundry products, hair care products, home care products, and a variety of oral care products.
Procter & Gamble Hygiene & Health Care markets its products under well-known brands like Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice. Distribution occurs through various channels, including mass merchandisers, grocery stores, membership clubs, drugstores, department stores, and high-frequency stores.
Incorporated in 1964 and based in Mumbai, India, Procter & Gamble Hygiene and Health Care operates as a subsidiary of The Procter & Gamble Company. Over the past 12 months, it has generated a revenue of Rs. 4,355.8 Crores and has been profitable, with a profit of Rs. 715.9 crores recorded in the previous four quarters.
The company also rewards its investors with dividends, having a yield of 1.44% per year. In the last year, it returned Rs. 205 dividend per share. The company's revenue has experienced a growth rate of 16.8% over the past three years, demonstrating its robust performance in the marketplace.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
PGHH vs Personal (2021 - 2026)